The legislation currently in place introduces a statutory defence for people eligible to receive palliation so that they can use illicit cannabis without fear of prosecution. In short, the purpose of the scheme currently in place is to improve access to quality medicinal cannabis products for patients on prescription from a doctor, and manufacturers and importers are required by the Medicinal Cannabis Agency to consistently meet minimum standards of quality before they can be supplied. Whilst we get our domestic manufacturers to get production of the quality and quantity we require, we have people that can't wait, and they won't be criminalised.